Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Stone

Showing results (81-90 of 110) with videos related to

Pageof 11
Sort By:
Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes|March 1, 1988
Magnetic resonance imaging, computed tomography, and radionuclide scintigraphy in detection of liver metastasesM J Bronskill, R M Henkelman, P Y Poon, et al.
Leukemia|May 24, 2016
KPT-8602, a second-generation inhibitor of XPO1-mediated nuclear export, is well tolerated and highly active against AML blasts and leukemia-initiating cellsJ Etchin, A Berezovskaya, A S Conway, et al.
Bone Marrow Transplantation|March 22, 2016
Does quality of life impact the decision to pursue stem cell transplantation for elderly patients with advanced MDS?A El-Jawahri, H T Kim, D P Steensma, et al.
Blood|September 6, 2001
Myelodysplastic syndromes standardized response criteria: further definitionB D Cheson, J M Bennett, H Kantarjian, et al.
Annals of Hematology|May 6, 2004
PKC 412 FLT3 inhibitor therapy in AML: results of a phase II trialR M Stone, J De Angelo, I Galinsky, et al.
Leukemia|February 16, 2011
Escalation of daunorubicin and addition of etoposide in the ADE regimen in acute myeloid leukemia patients aged 60 years and older: Cancer and Leukemia Group B Study 9720M R Baer, S L George, B L Sanford, et al.
Leukemia|May 26, 2012
Phase IB study of the FLT3 kinase inhibitor midostaurin with chemotherapy in younger newly diagnosed adult patients with acute myeloid leukemiaR M Stone, T Fischer, R Paquette, et al.
Leukemia|July 21, 2016
Adult acute myeloid leukemia with trisomy 11 as the sole abnormality is characterized by the presence of five distinct gene mutations: MLL-PTD, DNMT3A, U2AF1, FLT3-ITD and IDH2A-K Eisfeld, J Kohlschmidt, K Mrózek, et al.
Leukemia|December 17, 2015
Clinical features and gene- and microRNA-expression patterns in adult acute leukemia patients with t(11;19)(q23;p13.1) and t(11;19)(q23;p13.3)B Bhatnagar, J S Blachly, J Kohlschmidt, et al.
Blood|August 26, 1998
A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111R A Larson, R K Dodge, C A Linker, et al.
Pageof 11

Showing results (81-90 of 110) with videos related to

Sort By:
Pageof 11
Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes|March 1, 1988
Magnetic resonance imaging, computed tomography, and radionuclide scintigraphy in detection of liver metastasesM J Bronskill, R M Henkelman, P Y Poon, et al.
Leukemia|May 24, 2016
KPT-8602, a second-generation inhibitor of XPO1-mediated nuclear export, is well tolerated and highly active against AML blasts and leukemia-initiating cellsJ Etchin, A Berezovskaya, A S Conway, et al.
Bone Marrow Transplantation|March 22, 2016
Does quality of life impact the decision to pursue stem cell transplantation for elderly patients with advanced MDS?A El-Jawahri, H T Kim, D P Steensma, et al.
Blood|September 6, 2001
Myelodysplastic syndromes standardized response criteria: further definitionB D Cheson, J M Bennett, H Kantarjian, et al.
Annals of Hematology|May 6, 2004
PKC 412 FLT3 inhibitor therapy in AML: results of a phase II trialR M Stone, J De Angelo, I Galinsky, et al.
Leukemia|February 16, 2011
Escalation of daunorubicin and addition of etoposide in the ADE regimen in acute myeloid leukemia patients aged 60 years and older: Cancer and Leukemia Group B Study 9720M R Baer, S L George, B L Sanford, et al.
Leukemia|May 26, 2012
Phase IB study of the FLT3 kinase inhibitor midostaurin with chemotherapy in younger newly diagnosed adult patients with acute myeloid leukemiaR M Stone, T Fischer, R Paquette, et al.
Leukemia|July 21, 2016
Adult acute myeloid leukemia with trisomy 11 as the sole abnormality is characterized by the presence of five distinct gene mutations: MLL-PTD, DNMT3A, U2AF1, FLT3-ITD and IDH2A-K Eisfeld, J Kohlschmidt, K Mrózek, et al.
Leukemia|December 17, 2015
Clinical features and gene- and microRNA-expression patterns in adult acute leukemia patients with t(11;19)(q23;p13.1) and t(11;19)(q23;p13.3)B Bhatnagar, J S Blachly, J Kohlschmidt, et al.
Blood|August 26, 1998
A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111R A Larson, R K Dodge, C A Linker, et al.
Pageof 11